Abstract Background Patients with Parkinson's disease (PD) are at higher risk of COVID-19
infection as most of them are at older age. The goal of this study is to update the pooled …

SARS-CoV-2 infection leading to Coronavirus disease 19 (COVID-19) rapidly became a
worldwide health emergency due to its elevated infecting capacity, morbidity, and mortality …

Background Parkinson's disease has been identified as a risk factor for severe Coronavirus
disease 2019 (COVID-19) outcomes. However, whether the significant high risk of death …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus
disease 2019 (COVID-19), which was proclaimed a pandemic by the World Health …

Introduction. Parkinson's disease (PD) is the second most common neurological disorder.
Patients with PD were affected by the COVID‐19 pandemic in many different ways. This …

The COVID-19 pandemic has been a stress test for the population, especially for people with
chronic disorders such as Parkinson's disease (PD). In addition to public health restrictions …

Background: Parkinson's disease (PD) is the second most common neurodegenerative
disorder. This study aims to evaluate the direct medical costs of patients with PD using a …

The global explosion of COVID-19 necessitated the rapid dissemination of information
regarding SARS-CoV-2. Hence, COVID-19 prevalence and outcome data in Parkinson's …

Background The individualized clinical and public health management of the COVID-19
pandemic have changed over time, including care of people with PD. The objective was to …

Background: A century ago, a mystery between virus and Parkinson's disease (PD) was
described. Owing to the limitation of human brain biopsy and the challenge of electron …